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Surgical site infection (SSI) after dermatological surgery is associated with poor outcomes 
including increased recovery time, poor cosmesis and repeat visits to doctors. Prophylactic 
antibiotics are prescribed to reduce these adverse outcomes. Identifying risk factors for SSI 
will facilitate judicious antibiotic prophylaxis. 
Objectives:  
To identify risk factors for SSI after minor dermatological surgery. 
Design: 
Individual patient data from four large randomized controlled trials (RCTs) were combined to 
increase statistical power. 
Setting:  
Regional centre in North Queensland, Australia. 
Participants:  
A total of 3819 adult patients requiring minor skin procedures, were recruited for the four trials 
over a ten year period.  
Main Outcome Measure: 
Surgical site infection. 
Results:  
A total of 298 infections occurred in a population of 3819 patients, resulting in an overall 
incidence of 7.8% (95% CI 5.8-9.6), differing across the four studies (p=0.042). The risk 
factors identified were age (Relative Risk (RR) 1.01, 95% CI 1.001-1.020, p=0.008), excisions 
from the upper limbs (RR 3.03, 95% CI 1.76-5.22, p=0.007), lower limbs (RR 3.99, 95% CI 
1.93-8.23, p=0.009) and flap/2-layer procedures (RR 3.23, 95% CI 1.79-5.85, p=0.008). 




This study demonstrated that patients who were older, underwent complex excisions, or had 
excisions on the upper or lower limbs, were at higher risk of developing an SSI. An awareness 
of such risk factors will guide evidence based and targeted antibiotic prophylaxis.   
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Surgical site infection (SSI) following dermatological surgery is associated with 
prolonged wound healing, lengthened recovery time, poor cosmetic outcomes and increased 
costs to the health system.1 To avoid negative clinical outcomes for patients, primary care 
physicians often prescribe prophylactic antibiotics, however a known consequence of liberal 
antibiotic administration is  antibiotic resistance.2 Given that antibiotic stewardship guidelines 
recommend evidence based antibiotic prescription.3 awareness of patients who are at higher 
risk of infection is required to risk-stratify patients and encourage more judicious antibiotic 
management. 
In order to accurately define which patient groups are predisposed to SSI, a 
comprehensive understanding of patient, procedural and physician related risk factors is 
necessary. A recent systematic review undertaken by the first author showed that age, sex, 
histology and type and location of excision were risk factors for SSI following minor skin 
surgery.4 However, several of these studies were limited by small sample sizes and low 
incidence of infection.5-11 Furthermore, only two of these studies (857 patients 8.6%SSI; 972 
patients, 8.7% SSI) were carried out in primary care settings 8, 9. Given that a higher proportion 
of minor dermatological surgery takes place in primary care than in a hospital or specialist 
clinic setting in Australia,12 this particular area is not well represented in the literature. The 
review also highlighted the considerably higher incidence of infection in a North Queensland 
primary care population (8.7%) compared to the accepted rate of less than 5% following clean 
minor surgery.8, 9, 13 The high incidence of SSI makes this population an ideal setting to 
investigate risk factors for infection.  
The aim of this study was to identify the risk factors associated with SSI by conducting 
a secondary data analysis of the combined individual patient data from four previous 
randomised controlled trials (RCTs), 14-17 sourced through convenience sampling.  Each trial 
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was conducted by two or more authors of this paper, in a regional centre in North Queensland, 
Australia (Table 1).14-17 One trial described a difference between intervention and control 
groups that was statistically but not clinically significant.15 No significant difference was found 
between the arms of the other three RCTs and consequently all groups were considered together 




The data for this study were prospectively collected from four previously published 
RCTs conducted by one or more authors of the current manuscript.14-17. An overview of data 
collection methods for the four included trials is provided below (additional detail Table 1).  
Data collection methods of the included RCTs. 
The four RCTs included in this study were conducted in medical practices in the regional centre 
of Mackay, North Queensland, Australia. In these four studies, practice nurses were responsible 
for patient recruitment and demographic/clinical data collection, while general practitioners 
(GPs) performed the excisions and recorded details related to the excision, including length 
and type of excision. Across the four studies data was collected on demographics, smoker 
status, medical conditions (anaemia, diabetes, chronic obstructive pulmonary disease, 
peripheral vascular disease, ischaemic heart disease and cancer), medications (warfarin, 
clopidogrel, aspirin, steroids) and lesion and excision details.  A body map was used to define 
excision sites to ensure consistency among participating practices in the four included RCTs. 
All patients over the age of 18 presenting to their GP for removal of a skin lesion were eligible 
for recruitment to the RCTs. Only lesions removed by surgical excision were eligible for 
inclusion, not those involving shave biopsies, electrodesiccation or other methods of surgery. 
Patients were excluded if they were currently taking oral antibiotics or required immediate 
postoperative antibiotics or immunosuppressant medication. Repeat patients were excluded 
and patients were recruited for their first skin excision only during the recruitment period.  
A standardised surveillance criterion for superficial SSI developed by the Centers for Disease 
Control and Prevention (CDC) was employed consistently across the four included RCTs.14-17 
Surgical site infection was defined as infection of the skin only (or subcutaneous tissue of the 
excision occurring within 30 days of the excision and including at least one of: purulent 
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discharge, pain or tenderness, localised swelling, redness or heat and diagnosis of SSI by a 
general practitioner.18 Stitch abscess was not included as infection.  
Data collection protocol for combined individual patient data analysis 
 The raw data of the four RCTs were requested from the primary investigators CH 14,15,17  
and DC 16 (Table 1).  Included RCTs were purposely selected based on convenience sampling. 
Patient related risk factors such as age, gender, medical history, medication history and 
smoking status; lesion characteristics such as histology and location; and excision 
characteristics such as excision length, type, and the time until suture removal comprised the 
variables under analysis.  A ‘variable-matrix’ was produced to identify which variables were 
common to the four RCTs. Variables were either numeric or categorical. Numerical variables 
(e.g. age, length of excision) were directly comparable. Categorical variables varied in their 
coding such that a second ‘recoding-matrix’ was produced to visualise the individual coding 
of all variables, and produce a unique code for each variable/category to be used in the final 
data set. Not all characteristics from all studies were available for every patient and some 
variables were missing from entire studies. Of the medical condition variables analysed; cancer 
was recorded in three trials, 14-16 ischaemic heart disease was recorded separately in one trial 17 
and reported with other medical conditions in three trials, 14-16 while anaemia, 17 hypertension 
14 and inflammatory skin disease 16 were only recorded in one trial each. Of the medication 
variables; anticoagulants, inhaled steroids and oral steroids were recorded in three trials, 14-16 
and immuno-suppressants, 17 opioids 17 and disease-modifying-anti-rheumatic-drugs 16 were 
only recorded in one trial. Smoking status and excision length were recorded in three trials. 14-
16   
Statistical methods for combined individual patient data analysis 
Statistical analysis was performed using STATA-IC (version 14.0; StataCorp, TX, 
USA). Analyses were adjusted for the two-stage cluster sampling design (trial and recruiting 
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GP) using the svy commands in STATA. A p-value of less than 0.05 was considered 
statistically significant.  
For descriptive analysis of categorical data, absolute and relative frequencies were 
calculated. Incidence of SSI was presented with 95% confidence intervals (95% CI). Numerical 
data were first assessed for normality. All numerical variables in the data set (age, length of 
excision, time to suture removal) were skewed and were therefore described using median, 
interquartile range (IQR), and range. For inferential analysis comparing patients with SSI and 
those with no SSI, Chi-square and Fisher’s exact tests were applied for categorical variables, 
and Wilcoxon rank-sum tests were used for numerical data.  
Cluster-adjusted generalised linear modelling using Poisson regression was used to 
estimate relative risks and 95% CI. Categorical characteristics were analysed using indicator 
variables. Stepwise forward and backward selection processes were conducted to reach a 
model. All remaining characteristics that were not in this model were investigated for their 
potential confounding effects. A variable was considered a confounder if it altered the estimate 
by more than 10%. The final model was adjusted for all identified confounders. All possible 
two-way interactions of characteristics in the model were investigated.  
  
Study Approval 
Approval for this analysis was covered by the individual ethics approvals of the four included 
trials. Approval was provided by James Cook University Human Research Ethics Committee 
(H1902, H2590, H4572 and H6065). 
Results  
Data from 3819 patients were available for analysis and an overview of the four trials, 
including total sample size and incidence of SSI is presented in Table 1. Patient characteristics 
are presented in Table 2 and clinical details regarding the excisions are presented in Table 3. 
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The median age of the 3819 patients was 63 years, with a similar distribution of males to 
females (54.9% vs. 45.1%).  
[Table 1 here] 
[Table 2 here] 
[Table 3 here]  
Risk factors for surgical site infection 
SSI occurred in 298 (7.8%; 95% CI 5.8-9.6) of the 3819 skin excisions and the infection 
rates for the four trials were 7.3%, 9.0%, 9.0% and 6.3% (p=0.042) (Table 1).  Patients who 
developed a SSI were, on average, 6 years older than patients without a SSI (p=0.004). Of all 
the medical diagnoses recorded, only the presence of cancer was significantly associated with 
a higher incidence of SSI (p=0.029) (Table 2). Although patients who took any medication 
mentioned in the four trials had a higher incidence of infection (p=0.045), individually no 
medication was significantly associated with infection (Table 2). Patients who were current or 
ex-smokers had a higher incidence of infection compared to non-smokers, however this 
relationship was not statistically significant (p=0.261). 
 Skin excisions that took place on the upper limbs (10.6%) or lower limbs (10.8%) had 
a higher incidence of infection compared to other body sites (p=0.044) (Table 3). Excisions of 
squamous cell (12.8%), melanocytic (8.5%) and basal cell (8.4%) carcinomas were more likely 
to become infected compared to lesions with other histological classifications (p=0.006) (Table 
3). 
There was a statistically significant difference in the median duration to removal of 
sutures between the infected and non-infected lesions, although this difference was only one 
day (p=0.023). More complex procedures such as flap or 2-layer procedures were also more 
likely to develop SSI compared to simple elliptical excisions (p=0.002) (Table 3).  
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Multivariable generalised linear modelling (Table 4) confirmed that there was a 1.01 
times risk of infection per one-year increase in age (p=0.008). Excisions from the lower limbs 
were 3.99 times more likely, excisions from the upper limbs  3.03 times more likely and 
excisions from the trunk  2.07 times more likely to become infected compared to excisions on 
the head or neck (p=0.009, 0.007 and 0.031 respectively).  The type of excision (flap/2-layer 
vs. simple excisions) was also an independent predictor of SSI (p=0.008).  




Our results suggest that increasing age, excisions from the trunk, upper or lower limbs 
and flap/2-layer procedures are significant independent risk factors for SSI. Similar results have 
been demonstrated in previous literature.6-9  
 Few studies have identified age as a risk factor for SSI, and it was not an identified risk 
factor in any of the individual trial analyses. Although the risk per one-year increase is small, 
this indicates a relationship between increasing age and SSI risk, particularly when the age 
difference is larger. Only one other study reported similar findings, describing an increased 
risk of SSI with age over 50 years.7 While there is no explicit evidence that explains the 
relationship between age and SSI, aging is known to negatively impact wound healing through 
many physiological processes.19 This relationship might explain the increased risk of SSI. 
Further exploration of this risk factor (i.e. identifying an appropriate age threshold) is required 
before translating this finding to practice.  
 Upper and lower limb excisions were risk factors for SSI in this study, which is 
consistent with several studies conducted in both hospital and primary care settings.5, 8, 9, 11, 20 
Body extremities have reduced perfusion and compromised circulation compared to more 
central areas, implying a poorer wound healing process, which may explain why this 
phenomenon was observed. Excisions on the trunk were also significantly associated with SSI.  
However the observed incidence of SSI was only 1.8% higher compared to the reference 
category of head and neck excisions (Table 3), and such a minor difference might be considered 
clinically irrelevant. The statistical significance was due to the large sample size of the study 
and its respective power to detect even negligible differences.  
 Patients who received flap or 2-layer procedures for more complicated wounds were 
approximately three times more likely to develop an SSI compared to patients who received 
simple elliptical excisions. This relationship has been explored in three other studies.10, 11, 21. 
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More complex procedures such as these, although designed to reduce wound tension, have a 
higher overall tension compared to small wound closures. It is possible that higher wound 
tension makes the site more susceptible to wound breakage and opening, and therefore to 
subsequent infection. 
 The histology of excised lesions has been discussed as a predictor of SSI in earlier 
literature.8, 9 In this dataset, excisions of melanocytic (melanoma) and non-melanocytic 
(squamous and basal cell carcinoma) skin cancers were significantly associated with a higher 
incidence of infection on bivariate analysis, however this relationship was not shown to be 
independently significant in the multivariate model. As malignant skin lesions are more likely 
to occur on the extremities due to cumulative sun exposure,22-24 there was a high degree of 
correlation between histology and body site. Indeed, histology of the lesion was identified as a 
confounder of body site in the multivariable analysis and the model was adjusted for its effects. 
There were several advantages to our approach of combining individual patient data 
from a convenience sample of four randomised controlled trials previously conducted by the 
researchers. The original raw data from these trials were immediately available to the 
researchers. This data was collected prospectively from similar patient groups, and therefore 
the clinically homogenous nature of this data allowed for meaningful synthesis. Combination 
of this data allowed analysis of a very large patient population, providing increased statistical 
power to identify risk factors for infection.  
 
Limitations 
The limitations of this study design is that the sample was limited to studies conducted 
in one centre, and generalizability may be impacted by two factors; 1) all trials involved were 
carried out in a regional, hot and humid tropical setting and 2) the occupations of the patients 
included in the study would differ from those residing in a metropolitan area, introducing 
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factors such as risk of injury and exposure to different microbial species. It is possible that the 
warm and humid climate of North Queensland is associated with a higher incidence of 
infection. As such, the findings of this study might not be directly applicable to other areas 
which may or may not impact the infection rate and the risk factors involved.   
 Some variables (or categories of variables) were not collected in certain trials and these 
variables were omitted from the final multivariable model, reducing the overall power of the 
analysis. A further limitation is that the data from the included studies was not collected 
specifically for the purposes of a combined individual patient data analysis. Imputation of data 
is routinely performed to rectify this issue, however the missing values were often for entire 
trials, making imputation unfeasible. Although information pertaining to past medical history 
was collected by practice nurses, medical diagnoses were extracted from the practice’s medical 
management software, rather than standardised diagnostic criteria. This may explain the lack 
of any significant associations between past medical history and incidence of infection.  
Conclusion. 
Antibiotic prophylaxis is prescribed unnecessarily for patients undergoing minor 
dermatological surgery, and should be restricted to patients who are at higher risk of developing 
a SSI. This combined data-analysis identified that older age, excisions from the upper and 
lower limbs and flap or 2-layer procedures were significant risk factors for SSI in a large 
general practice cohort. We hope that the identification of these risk factors will help to 
encourage judicious antibiotic prophylaxis for patients undergoing minor skin surgery in 
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of SSI % 
Heal et al.17 
2006 
Multicentre randomised controlled trial. Consecutive 
patients presenting for minor skin excision. Dry 
covered wounds (control) vs wounds uncovered and 
wet within 48 hrs of excision (intervention). 
Exclusions: patients on/clinically indicated for 
antibiotics, lacerations, flap or two layer procedures, 





Heal et al.15 
2009 
Multicentre double blind randomised controlled trial. 
Consecutive patients presenting for minor skin 
excision. Single dose topical chloramphenicol 
(intervention) vs paraffin ointment (control). 
Exclusions: patients on/clinically indicated for 
antibiotics, patients on immune-suppressants, excision 
of sebaceous cyst, allergy to chloramphenicol and 




Heal et al.14 
2015 
Single centre randomised controlled trial. Consecutive 
patients presenting for minor skin excision. Clean 
boxed non-sterile gloves (intervention) vs sterile gloves 
(control). Exclusions: patients on antibiotics or 
immune-suppressants, skin flaps, excision of sebaceous 




Charles et al.16 
2016 
Multi centre randomised controlled trial. Consecutive 
patients presenting for minor skin excision. Topical 
application of 0.5% chlorhexidine in 70% ethanol 
(intervention) vs 0.5% chlorhexidine in aqueous 
solution. Exclusions: patients on antibiotics, excision 





Total Total 3819 298 7.8 
Table 1 Legend. RCTs included in the IPD meta-analysis. The studies included one equivalence 
study,17 one non-inferiority study,14 and two studies testing for difference.15, 16 Sample sizes in 




Table 2.  
Patient characteristicsb Overall 
(n=3819) 




Agec (IQR)d, range (n=3794) 
63 (50, 73);  
range 5 to 101 
68(58,75); 









Medical conditions (%)     




Anaemia4 (n=478) 1 (0%) 0 (0%) 0.0% 
 
P=1.0  
















Ischaemic Heart Disease3,4 
(n=1663) 




Inflammatory Skin Disease1 
(n=909) 








Medications (%)     




























Medications cont. (%) 
Oral steroids14-16 (n=2572)  







drugs16 (n=478)  





























Table 2 Legend. Description of patient characteristics of 3819 patients undergoing minor skin excision 
and comparisons between patients with and patients without surgical site infection (SSI). The data 
combines results from 4 clinical trials. ap-values: first p-value is result of unadjusted analysis and second 
p-value is adjusted for cluster sampling of data. bNot all characteristics were assessed for all trials; trial 
number and/or sample sizes stated for variables with less than 3819 valid entries; cage (years) presented 
as median; dIQR = inter-quartile range; eDenominator for “any” condition or medication mentioned in 
pooled data combines “no” and “missing values” for trials which did not record certain conditions or 
medications. Superscript numbers adjacent to variables denote which trial the variable was recorded in. 





Excision characteristicb Overall 
(n=3819) 
SSI (n=298) SSI rate p-valuea 
 






Basal Cell Carcinoma 854 (22.4%) 72 (24.2%) 8.4%  
Squamous Cell Carcinoma/ 
Bowen’s disease 
935 (24.5%) 120 (40.3%) 12.8% 
 
Melanoma 59 (1.5%) 5 (1.7%) 8.5%  
Benign naevus 333 (8.7%) 10 (3.4%) 3.0%  
Dysplastic naevus 90 (2.4%) 2 (0.7%) 2.2%  
Actinic keratosis 775 (20.3%) 62 (20.8%) 8.0%  
Seborrheic keratosis 220 (5.8%) 9 (3.0%) 4.1%  
Other histologyc 552 (14.5%) 18 (6.0%) 3.3%  
Location (%) (n=3794)    P<0.001 
P=0.044 
Head and neck 869 (22.9%) 26 (8.8%) 3.0%  
Upper limbs 1269 (33.4%) 134 (45.6%) 10.6%  
Trunk 736 (19.4%) 35 (11.9%) 4.8%  
Lower limbs 920 (24.2%) 99 (33.7%) 10.8%  
Excision lengthd 1,3,4 (IQR); range 
(n=2572) 
20 (15, 30); 
range 1.5 to 100 
27 (20, 38);      





Flap/2-layer procedure (%) 
(n=3815) 




Days to suture removale (IQR); 
range (n=3710) 
8 (7, 10);     
range 1 to 37 






Table 3. Description of excision characteristics of 3819 patients undergoing minor skin excision and 
comparisons between patients with and patients without surgical site infection (SSI). The data combines 
results from 4 clinical trials. ap-values: first p-value is result of unadjusted analysis and second p-value 
is adjusted for cluster sampling of data. bNot all characteristics were assessed for all trials; trial number 
and/or sample sizes stated for variables with less than 3819 valid entries; cOther histology included 
basal cell papilloma, re-excisions of melanoma, dysplastic naevus, and non-melanoma skin cancers; 
dexcision length (mm) presented as median; enumber of days until sutures were removed, presented as 
median; / = no result calculated as there were too few events observed. Superscript numbers adjacent 
to variables denote which trial the variable was recorded in. No number indicates the variable was 





Table 4 Legend. Result of generalised linear modelling of risk factors for SSI in 3787 
patients with minor skin surgery. *Age is a continuous characteristic. Model was adjusted for 
the confounding effects of histology of lesion.   
  









Age [years] /* / 1.01 1.001 to 1.02 P=0.008 
Body site of lesion 
  Head and Neck 
  Upper limbs 
  Trunk 


















1.76 to 5.22 
1.13 to3.79 






Type of excision 
  Simple excision 












1.79 to 5.85 
 
 
P=0.008 
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